电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Recombinant EGFR (Cetuximab Biosimilar) 抗体

This anti-EGFR (Cetuximab Biosimilar) antibody is a 小鼠 单克隆 antibody detecting EGFR (Cetuximab Biosimilar) in FACS 和 in vivo. Suitable for 人.
产品编号 ABIN7795079
发货至: 中国

Quick Overview for Recombinant EGFR (Cetuximab Biosimilar) 抗体 (ABIN7795079)

抗原

EGFR (Cetuximab Biosimilar)

抗体类型

Recombinant Antibody

适用

  • 7
  • 1

宿主

  • 3
  • 1
  • 1
  • 1
  • 1
小鼠

克隆类型

  • 4
  • 3
单克隆

标记

  • 7
This EGFR (Cetuximab Biosimilar) antibody is un-conjugated

应用范围

  • 4
  • 3
  • 1
  • 1
Flow Cytometry (FACS), In vivo Studies (in vivo)

质量等级

Research Grade
  • Expression System

    Mammalian cells

    原理

    Cetuximab Biosimilar, Endotoxin 0.05 EU/mg

    产品特性

    Cetuximab, a chimeric (mouse/human) anti-EGFR monoclonal antibody, is an EGFR inhibitor used for the treatment of metastatic colorectal cancer and head and neck cancer. Cetuximab binds to EGFR and turns off the uncontrolled growth in cancers with EGFR mutations. Cetuximab can be used for treatment of KRAS wild type colon cancer but has little or no effect in colorectal tumors harboring a KRAS mutation. Before treatment using Erbitux, it is better to do a diagnosis using the real time PCR companion diagnostic test for KRAS, the therascreen KRAS test. There are four closely related receptor tyrosine kinases in the ErbB family of receptors: EGFR (ErbB-1, HER1 in humans), HER2/c-neu (ErbB-2), Her 3 (ErbB-3) and Her 4 (ErbB-4). Bound by members of the epidermal growth factor family (EGF-family) of extracellular protein ligands, EGFR (epidermal growth factor receptor) located on cell surface sends a signal down the MAPK pathway that includes another protein, KRAS (also spelled K-ras). Mutations affecting EGFR and/or KRAS expression or activity could result in cancer. The mutated KRAS continuously sends a growth signal to the downstream pathway, leading to uncontrollable cell division, even if EGFR has been blocked.

    纯化方法

    Protein A or G affinity column

    纯度

    >95 % by reducing SDS-PAGE

    内毒素水平

    Less than 0.5 EU/mg of protein as determined by LAL method

    免疫原

    Human EGFR / ErbB-1

    亚型

    IgG1
  • 应用备注

    Optimal working dilution should be determined by the investigator.

    限制

    仅限研究用
  • 状态

    Liquid

    浓度

    > 3 mg/mL

    储存条件

    4 °C,-20 °C

    储存方法

    Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.
  • 抗原

    EGFR (Cetuximab Biosimilar)

    别名

    Cetuximab Biosimilar

    物质类

    Biosimilar
You are here:
Chat with us!